logo
Breadcrumbs Image

Antibacterial Drug Resistance Market

Antibacterial Drug Resistance Market

Global Antibacterial Drug Resistance Market Research Report 2021 Professional Edition


Date: Apr-2021 | Id: MACRC-37822 | Geographical Scope: Global | Publisher: HNY Research

The research team projects that the Antibacterial Drug Resistance market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.

The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

By Market Players:
AAIPharma Services
ANTABIO
Abgentis
Abbott Laboratories
Absynth Biologics
Achaogen
Acino Holdings
Aventis Pharma
Austell Laboratories
Assembly Biosciences
Arpida
Demuris
Evolva Holding
ContraFect
Cerexa
GSK
InterMune
Isis Pharmaceuticals
Lyndra
Microbecide
Morphochem
Nabriva Therapeutics
NanoSafe Coatings
Novexel
Osel
PENDOPHARM
Pfizer
VenatoRx Pharmaceuticals

By Type
Telavancin (Vibativ)
Ceftaroline Fosamil (Teflaro/ Zinforo)
Fidaxomicin (Dificid / Dificlir)
Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)
Dalbavancin (Dalvance/ Xydalba)
Tedizolid Phosphate (Sivextro)
Oritavancin (Orbactiv/ Nuvocid)
Ceftolozane-Tazobactam (Zerbaxa)
Ceftazidime-Avibactam (Avycaz/ Zavicefta)

By Application
Gram-Positive
Gram-Negative

By Regions/Countries:
North America
United States
Canada
Mexico

East Asia
China
Japan
South Korea

Europe
Germany
United Kingdom
France
Italy
Russia
Spain
Netherlands
Switzerland
Poland

South Asia
India
Pakistan
Bangladesh

Southeast Asia
Indonesia
Thailand
Singapore
Malaysia
Philippines
Vietnam
Myanmar

Middle East
Turkey
Saudi Arabia
Iran
United Arab Emirates
Israel
Iraq
Qatar
Kuwait
Oman

Africa
Nigeria
South Africa
Egypt
Algeria
Morocoo

Oceania
Australia
New Zealand

South America
Brazil
Argentina
Colombia
Chile
Venezuela
Peru
Puerto Rico
Ecuador

Rest of the World
Kazakhstan

Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global  market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Antibacterial Drug Resistance 2016-2021, and development forecast 2022-2027 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2020.

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2021 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2022-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Antibacterial Drug Resistance Industry, including its product specifcations by each key player, volume, sales by Volume and Value (M USD).
Markat Analysis by Application Type: Based on the Antibacterial Drug Resistance Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Antibacterial Drug Resistance market in 2021. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

Get Started with Request an Overview
Get Started with Download Brochure
Get Started with Request Methodology
Get Started with Share Customization
Get Started with Submit RFP
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Antibacterial Drug Resistance Revenue
1.4 Market Analysis by Type
1.4.1 Global Antibacterial Drug Resistance Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Telavancin (Vibativ)
1.4.3 Ceftaroline Fosamil (Teflaro/ Zinforo)
1.4.4 Fidaxomicin (Dificid / Dificlir)
1.4.5 Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)
1.4.6 Dalbavancin (Dalvance/ Xydalba)
1.4.7 Tedizolid Phosphate (Sivextro)
1.4.8 Oritavancin (Orbactiv/ Nuvocid)
1.4.9 Ceftolozane-Tazobactam (Zerbaxa)
1.4.10 Ceftazidime-Avibactam (Avycaz/ Zavicefta)
1.5 Market by Application
1.5.1 Global Antibacterial Drug Resistance Market Share by Application: 2022-2027
1.5.2 Gram-Positive
1.5.3 Gram-Negative
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Antibacterial Drug Resistance Market
1.8.1 Global Antibacterial Drug Resistance Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Antibacterial Drug Resistance Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Antibacterial Drug Resistance Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Antibacterial Drug Resistance Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Antibacterial Drug Resistance Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Antibacterial Drug Resistance Sales Volume Market Share by Region (2016-2021)
3.2 Global Antibacterial Drug Resistance Sales Revenue Market Share by Region (2016-2021)
3.3 North America Antibacterial Drug Resistance Sales Volume
3.3.1 North America Antibacterial Drug Resistance Sales Volume Growth Rate (2016-2021)
3.3.2 North America Antibacterial Drug Resistance Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Antibacterial Drug Resistance Sales Volume
3.4.1 East Asia Antibacterial Drug Resistance Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Antibacterial Drug Resistance Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Antibacterial Drug Resistance Sales Volume (2016-2021)
3.5.1 Europe Antibacterial Drug Resistance Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Antibacterial Drug Resistance Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Antibacterial Drug Resistance Sales Volume (2016-2021)
3.6.1 South Asia Antibacterial Drug Resistance Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Antibacterial Drug Resistance Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Antibacterial Drug Resistance Sales Volume (2016-2021)
3.7.1 Southeast Asia Antibacterial Drug Resistance Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Antibacterial Drug Resistance Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Antibacterial Drug Resistance Sales Volume (2016-2021)
3.8.1 Middle East Antibacterial Drug Resistance Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Antibacterial Drug Resistance Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Antibacterial Drug Resistance Sales Volume (2016-2021)
3.9.1 Africa Antibacterial Drug Resistance Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Antibacterial Drug Resistance Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Antibacterial Drug Resistance Sales Volume (2016-2021)
3.10.1 Oceania Antibacterial Drug Resistance Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Antibacterial Drug Resistance Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Antibacterial Drug Resistance Sales Volume (2016-2021)
3.11.1 South America Antibacterial Drug Resistance Sales Volume Growth Rate (2016-2021)
3.11.2 South America Antibacterial Drug Resistance Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Antibacterial Drug Resistance Sales Volume (2016-2021)
3.12.1 Rest of the World Antibacterial Drug Resistance Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Antibacterial Drug Resistance Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Antibacterial Drug Resistance Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Antibacterial Drug Resistance Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Antibacterial Drug Resistance Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Antibacterial Drug Resistance Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Antibacterial Drug Resistance Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Antibacterial Drug Resistance Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Antibacterial Drug Resistance Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Antibacterial Drug Resistance Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Antibacterial Drug Resistance Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Antibacterial Drug Resistance Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Antibacterial Drug Resistance Sales Volume Market Share by Type (2016-2021)
14.2 Global Antibacterial Drug Resistance Sales Revenue Market Share by Type (2016-2021)
14.3 Global Antibacterial Drug Resistance Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Antibacterial Drug Resistance Consumption Volume by Application (2016-2021)
15.2 Global Antibacterial Drug Resistance Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Antibacterial Drug Resistance Business
16.1 AAIPharma Services
16.1.1 AAIPharma Services Company Profile
16.1.2 AAIPharma Services Antibacterial Drug Resistance Product Specification
16.1.3 AAIPharma Services Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 ANTABIO
16.2.1 ANTABIO Company Profile
16.2.2 ANTABIO Antibacterial Drug Resistance Product Specification
16.2.3 ANTABIO Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Abgentis
16.3.1 Abgentis Company Profile
16.3.2 Abgentis Antibacterial Drug Resistance Product Specification
16.3.3 Abgentis Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Abbott Laboratories
16.4.1 Abbott Laboratories Company Profile
16.4.2 Abbott Laboratories Antibacterial Drug Resistance Product Specification
16.4.3 Abbott Laboratories Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Absynth Biologics
16.5.1 Absynth Biologics Company Profile
16.5.2 Absynth Biologics Antibacterial Drug Resistance Product Specification
16.5.3 Absynth Biologics Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Achaogen
16.6.1 Achaogen Company Profile
16.6.2 Achaogen Antibacterial Drug Resistance Product Specification
16.6.3 Achaogen Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Acino Holdings
16.7.1 Acino Holdings Company Profile
16.7.2 Acino Holdings Antibacterial Drug Resistance Product Specification
16.7.3 Acino Holdings Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Aventis Pharma
16.8.1 Aventis Pharma Company Profile
16.8.2 Aventis Pharma Antibacterial Drug Resistance Product Specification
16.8.3 Aventis Pharma Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Austell Laboratories
16.9.1 Austell Laboratories Company Profile
16.9.2 Austell Laboratories Antibacterial Drug Resistance Product Specification
16.9.3 Austell Laboratories Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Assembly Biosciences
16.10.1 Assembly Biosciences Company Profile
16.10.2 Assembly Biosciences Antibacterial Drug Resistance Product Specification
16.10.3 Assembly Biosciences Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Arpida
16.11.1 Arpida Company Profile
16.11.2 Arpida Antibacterial Drug Resistance Product Specification
16.11.3 Arpida Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Demuris
16.12.1 Demuris Company Profile
16.12.2 Demuris Antibacterial Drug Resistance Product Specification
16.12.3 Demuris Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 Evolva Holding
16.13.1 Evolva Holding Company Profile
16.13.2 Evolva Holding Antibacterial Drug Resistance Product Specification
16.13.3 Evolva Holding Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.14 ContraFect
16.14.1 ContraFect Company Profile
16.14.2 ContraFect Antibacterial Drug Resistance Product Specification
16.14.3 ContraFect Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.15 Cerexa
16.15.1 Cerexa Company Profile
16.15.2 Cerexa Antibacterial Drug Resistance Product Specification
16.15.3 Cerexa Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.16 GSK
16.16.1 GSK Company Profile
16.16.2 GSK Antibacterial Drug Resistance Product Specification
16.16.3 GSK Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.17 InterMune
16.17.1 InterMune Company Profile
16.17.2 InterMune Antibacterial Drug Resistance Product Specification
16.17.3 InterMune Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.18 Isis Pharmaceuticals
16.18.1 Isis Pharmaceuticals Company Profile
16.18.2 Isis Pharmaceuticals Antibacterial Drug Resistance Product Specification
16.18.3 Isis Pharmaceuticals Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.19 Lyndra
16.19.1 Lyndra Company Profile
16.19.2 Lyndra Antibacterial Drug Resistance Product Specification
16.19.3 Lyndra Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.20 Microbecide
16.20.1 Microbecide Company Profile
16.20.2 Microbecide Antibacterial Drug Resistance Product Specification
16.20.3 Microbecide Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.21 Morphochem
16.21.1 Morphochem Company Profile
16.21.2 Morphochem Antibacterial Drug Resistance Product Specification
16.21.3 Morphochem Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.22 Nabriva Therapeutics
16.22.1 Nabriva Therapeutics Company Profile
16.22.2 Nabriva Therapeutics Antibacterial Drug Resistance Product Specification
16.22.3 Nabriva Therapeutics Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.23 NanoSafe Coatings
16.23.1 NanoSafe Coatings Company Profile
16.23.2 NanoSafe Coatings Antibacterial Drug Resistance Product Specification
16.23.3 NanoSafe Coatings Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.24 Novexel
16.24.1 Novexel Company Profile
16.24.2 Novexel Antibacterial Drug Resistance Product Specification
16.24.3 Novexel Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.25 Osel
16.25.1 Osel Company Profile
16.25.2 Osel Antibacterial Drug Resistance Product Specification
16.25.3 Osel Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.26 PENDOPHARM
16.26.1 PENDOPHARM Company Profile
16.26.2 PENDOPHARM Antibacterial Drug Resistance Product Specification
16.26.3 PENDOPHARM Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.27 Pfizer
16.27.1 Pfizer Company Profile
16.27.2 Pfizer Antibacterial Drug Resistance Product Specification
16.27.3 Pfizer Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.28 VenatoRx Pharmaceuticals
16.28.1 VenatoRx Pharmaceuticals Company Profile
16.28.2 VenatoRx Pharmaceuticals Antibacterial Drug Resistance Product Specification
16.28.3 VenatoRx Pharmaceuticals Antibacterial Drug Resistance Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Antibacterial Drug Resistance Manufacturing Cost Analysis
17.1 Antibacterial Drug Resistance Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Antibacterial Drug Resistance
17.4 Antibacterial Drug Resistance Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Antibacterial Drug Resistance Distributors List
18.3 Antibacterial Drug Resistance Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Antibacterial Drug Resistance (2022-2027)
20.2 Global Forecasted Revenue of Antibacterial Drug Resistance (2022-2027)
20.3 Global Forecasted Price of Antibacterial Drug Resistance (2016-2027)
20.4 Global Forecasted Production of Antibacterial Drug Resistance by Region (2022-2027)
20.4.1 North America Antibacterial Drug Resistance Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Antibacterial Drug Resistance Production, Revenue Forecast (2022-2027)
20.4.3 Europe Antibacterial Drug Resistance Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Antibacterial Drug Resistance Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Antibacterial Drug Resistance Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Antibacterial Drug Resistance Production, Revenue Forecast (2022-2027)
20.4.7 Africa Antibacterial Drug Resistance Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Antibacterial Drug Resistance Production, Revenue Forecast (2022-2027)
20.4.9 South America Antibacterial Drug Resistance Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Antibacterial Drug Resistance Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Antibacterial Drug Resistance by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Antibacterial Drug Resistance by Country
21.2 East Asia Market Forecasted Consumption of Antibacterial Drug Resistance by Country
21.3 Europe Market Forecasted Consumption of Antibacterial Drug Resistance by Countriy
21.4 South Asia Forecasted Consumption of Antibacterial Drug Resistance by Country
21.5 Southeast Asia Forecasted Consumption of Antibacterial Drug Resistance by Country
21.6 Middle East Forecasted Consumption of Antibacterial Drug Resistance by Country
21.7 Africa Forecasted Consumption of Antibacterial Drug Resistance by Country
21.8 Oceania Forecasted Consumption of Antibacterial Drug Resistance by Country
21.9 South America Forecasted Consumption of Antibacterial Drug Resistance by Country
21.10 Rest of the world Forecasted Consumption of Antibacterial Drug Resistance by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer

Add to Cart

Single User

$ 2890.00

Site License

$ 4335.00

Enterprisewide

$ 5780.00